ANTIRETROVIRAL THERAPY
Clinical trials for ANTIRETROVIRAL THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANTIRETROVIRAL THERAPY trials appear
Sign up with your email to follow new studies for ANTIRETROVIRAL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simpler Two-Drug HIV regimen be just as effective as three?
Disease control Recruiting nowThis trial tests whether a two-drug combination (darunavir/cobicistat plus lamivudine) works as well as a standard three-drug combination (darunavir/cobicistat plus tenofovir alafenamide/emtricitabine) in people with HIV whose virus is already suppressed. The study involves 78 ad…
Matched conditions: ANTIRETROVIRAL THERAPY
Phase: PHASE4 • Sponsor: Instituto Mexicano del Seguro Social • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
HIV drug switch study aims to uncover hidden resistance risks
Knowledge-focused Recruiting nowThis study follows 420 adults with HIV whose virus is fully suppressed by medication. Researchers want to see if switching to a different HIV drug regimen causes hidden drug resistance to appear. They will compare people who switch drugs with those who stay on their current treat…
Matched conditions: ANTIRETROVIRAL THERAPY
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC